$ARGX News

argenx (ENXTBR:ARGX) Stock Looks Overvalued After Its 202% Five Year Run

argenx (ENXTBR:ARGX) Posted Q3 2026 Results, Is It Fully Priced?

argenx (ENXTBR:ARGX) Reports Positive Phase 3 Data In Autoimmune Myositis

Argenx (ENXTBR:ARGX) Stock Faces Margin Questions After Q3 Earnings

Argenx's Vyvgart Sales Growth, Pipeline Progress Support Outlook, Oppenheimer Says

Argenx's Vyvgart Beats Expectations With Focus Shifting to December Data, RBC Says

Morgan Stanley Maintains Overweight on argenx, Raises Price Target to $1190

argenx: 3 Key Takeaways for Long-Term Investors

Guggenheim Maintains Buy on argenx, Lowers Price Target to $1120

Wells Fargo Maintains Overweight on argenx, Lowers Price Target to $1336

Evercore ISI Group Maintains Outperform on argenx, Raises Price Target to $1090

argenx (ARGX) Q3 2026 Earnings Call Transcript

Baird Maintains Neutral on argenx, Raises Price Target to $861

Argenx Wavers After A Surprise Testing Setback For Its Bread-And-Butter Drug

What argenex (ARGX) Said on Its Q3 Earnings Call

HRMY or ARGX: Which Is the Better Value Stock Right Now?

Argenx slips as Q3 operating profit miss offsets Vyvgart sales beat

argenx Q3 2026 Earnings Call Transcript

argenx Reports Third Quarter 2026 Financial Results and Provides Business Update

argenx Q3 EPS $7.80 Misses $7.83 Estimate, Sales $1.751B Beat $1.664B Estimate